Clinical Trial Update: TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether omeprazole-induced stomach pH changes influence blood levels of rilpivirine (TMC278) in healthy volunteers; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV Infections | Phase 1 | Status: COMPLETED